| Chemically defined generation of human cardiomyocytes PW Burridge, E Matsa, P Shukla, ZC Lin, JM Churko, AD Ebert, F Lan, ... Nature methods 11 (8), 855-860, 2014 | 1721 | 2014 |
| Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming PW Burridge, G Keller, JD Gold, JC Wu Cell stem cell 10 (1), 16-28, 2012 | 809 | 2012 |
| Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity PW Burridge, YF Li, E Matsa, H Wu, SG Ong, A Sharma, A Holmström, ... Nature medicine 22 (5), 547-556, 2016 | 728 | 2016 |
| A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability PW Burridge, S Thompson, MA Millrod, S Weinberg, X Yuan, A Peters, ... PloS one 6 (4), e18293, 2011 | 474 | 2011 |
| A physical map of the mouse genome SG Gregory, M Sekhon, J Schein, S Zhao, K Osoegawa, CE Scott, ... Nature 418 (6899), 743-750, 2002 | 435 | 2002 |
| High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells A Sharma, PW Burridge, WL McKeithan, R Serrano, P Shukla, N Sayed, ... Science translational medicine 9 (377), eaaf2584, 2017 | 377 | 2017 |
| Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability PW Burridge, D Anderson, H Priddle, MD Barbadillo Muñoz, ... Stem Cells 25 (4), 929-938, 2007 | 374 | 2007 |
| Screening drug-induced arrhythmia using human induced pluripotent stem cell–derived cardiomyocytes and low-impedance microelectrode arrays EG Navarrete, P Liang, F Lan, V Sanchez-Freire, C Simmons, T Gong, ... Circulation 128 (11_suppl_1), S3-S13, 2013 | 354 | 2013 |
| Human stem cells for modeling heart disease and for drug discovery E Matsa, PW Burridge, JC Wu Science translational medicine 6 (239), 239ps6-239ps6, 2014 | 252 | 2014 |
| Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells PW Burridge, A Holmström, JC Wu Current protocols in human genetics 87 (1), 21.3. 1-21.3. 15, 2015 | 227 | 2015 |
| Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro E Matsa, PW Burridge, KH Yu, JH Ahrens, V Termglinchan, H Wu, C Liu, ... Cell stem cell 19 (3), 311-325, 2016 | 182 | 2016 |
| Human induced pluripotent stem cell–derived cardiomyocytes as an in vitro model for coxsackievirus B3–induced myocarditis and antiviral drug screening platform A Sharma, C Marceau, R Hamaguchi, PW Burridge, K Rajarajan, ... Circulation research 115 (6), 556-566, 2014 | 172 | 2014 |
| MicroRNA-302 increases reprogramming efficiency via repression of NR2F2 S Hu, KD Wilson, Z Ghosh, L Han, Y Wang, F Lan, KJ Ransohoff, ... Stem cells 31 (2), 259-268, 2013 | 172 | 2013 |
| Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity E Gu, WY Chen, J Gu, P Burridge, JC Wu Theranostics 2 (4), 335, 2012 | 154 | 2012 |
| Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling OJ Abilez, E Tzatzalos, H Yang, MT Zhao, G Jung, AM Zöllner, M Tiburcy, ... Stem cells 36 (2), 265-277, 2018 | 152 | 2018 |
| A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards NM Mordwinkin, PW Burridge, JC Wu Journal of cardiovascular translational research 6, 22-30, 2013 | 152 | 2013 |
| Use of human induced pluripotent stem cell–derived cardiomyocytes to assess drug cardiotoxicity A Sharma, WL McKeithan, R Serrano, T Kitani, PW Burridge, ... Nature protocols 13 (12), 3018-3041, 2018 | 148 | 2018 |
| Lymphoangiocrine signals promote cardiac growth and repair X Liu, E De la Cruz, X Gu, L Balint, M Oxendine-Burns, T Terrones, W Ma, ... Nature 588 (7839), 705-711, 2020 | 145 | 2020 |
| Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation A Sharma, G Li, K Rajarajan, R Hamaguchi, PW Burridge, SM Wu Journal of visualized experiments: JoVE, 52628, 2015 | 136 | 2015 |
| Use of human induced pluripotent stem cell–derived cardiomyocytes in preclinical cancer drug cardiotoxicity testing: a scientific statement from the American Heart Association G Gintant, P Burridge, L Gepstein, S Harding, T Herron, C Hong, J Jalife, ... Circulation research 125 (10), e75-e92, 2019 | 133 | 2019 |
